SEC Form 4 · accession 0001209191-17-026299
CUMBERLAND PHARMACEUTICALS INC · CPIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leo Pavliv
Officer — SVP and Chief Development Off.
Period of report
Apr 7, 2017
Accepted (ET)
Apr 7, 2017 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001087294
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2017 | A | 10,000 | $6.45 | A | 111,443 | D | |
| Common StockF2 | Apr 7, 2017 | F | 3,582 | $6.45 | D | 107,861 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock award will vest 100% on March 17, 2021.
- F2This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 10,000 shares during March 2017.